The short version of human growth hormone fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-18. Anything still debated is marked as such rather than presented as settled.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Canadian literature is often divided into French- and English-language literatures, which are rooted in the literary traditions of France and Britain, respectively. The earliest Canadian narratives were of travel and exploration. This developed into three major themes of historical Canadian literature: nature, frontier life, and Canada's position within the world, all of which tie into the garrison mentality. The evolution of Canadian literature is intricately linked to the country's historical and social contexts, often mirroring the challenges and changes in Canadian society. As Canadian literature progressed into the 20th and 21st centuries, it began to address a broader array of subjects and themes, such as women's rights, LGBTQ rights, immigrant experiences, environmental issues, the relationship with Indigenous peoples, and Canadian values and identity. Financial support from governmental bodies, such as the Canada Council for the Arts and various provincial grant programs, facilitates the creation, publication, and promotion of works by Canadian authors. Numerous Canadian authors have received international literary awards including the Nobel Prize in Literature, the Booker Prize, and the Pulitzer Prize for Fiction. Canadian literary awards and prizes include the Governor General's Literary Awards, the Giller Prize, the Latner Griffin Writers' Trust Poetry Prize, the Burt Award for First Nations, Inuit and Métis Literature and several accolades for literature aimed at children.
== Diagnosis == Buried bumper syndrome may be suspected based on features consistent with this disorder. The diagnosis is confirmed either endoscopically (via upper endoscopy) or with computed tomography. Upper endoscopy may reveal overgrowth of stomach tissue over the internal bumper (incomplete buried bumper syndrome). If the bumper has eroded deep into the gastric mucosa, it may not be visualized during endoscopic evaluation (complete buried bumper syndrome).
The four substrates of this enzyme are albendazole, reduced nicotinamide adenine dinucleotide phosphate (NADPH), oxygen and a proton. Its products are ricobendazole (albendazole S-oxide), oxidised NADP+, and water. This enzyme is coded by the gene for FMO3 and is a flavin-containing monooxygenase that uses molecular oxygen as oxidant and incorporates one of its atoms into the starting material. The systematic name of this enzyme class is albendazole,NADPH:oxygen oxidoreductase (sulfoxide-forming). Other names in common use include albendazole oxidase, and albendazole sulfoxidase. It employs one cofactor, flavin adenine dinucleotide.
=== Economic reforms === The FSN had to choose between the two economic models that political elites claimed were available to post-Communist Eastern European countries: shock therapy or gradual reforms. The FSN chose the latter, slower reforms, because it would have not been possible to convince the people who were already "exhausted" after Ceaușescu's austerity to undergo further sacrifices. Nevertheless, neoliberal reforms were implemented, although not all at once: by the end of 1990, prices were liberalised and a free currency exchange rate was implemented, devaluing the leu by 60%. The land of the state-owned collective farms was distributed to private owners and a list of 708 large state-owned enterprises to be privatised was devised. In 1991 Romania signed an agreement with the IMF and began the privatisation of state-owned enterprises, with the first privatisation law being passed in 1991. In 1992, the Stolojan government began an austerity plan, limiting wages and further liberalising prices. The economic situation deteriorated and inflation as well as unemployment increased substantially. The austerity measures, which by 1995 included a decrease in social spending, led to an increase in poverty. The neoliberal reforms were accelerated after the Democratic Convention won the 1996 elections, the government using its prerogatives to pass a package of laws, removing subsidies, passing reforms on unemployment benefits and greatly increasing the number of privatised companies.
In 2019, senior executives from A&W, presenting at a conference organized by LabourWatch, were recorded sharing the anti-union measures that the franchisor allegedly takes when made aware of potential unionization activity at any franchisee or corporate-owned locations. Nancy Wuttunee, the Vice President, People Potential and Mike Atkinson, then-Regional Vice President, Eastern Canada, divulged that A&W's Home Office keeps a "'watch list' of franchises that are 'high risk for unionizing'" and that, when alerted of potential unionization efforts, Wuttunee described that the company has a “fire drill” reaction, which is "a rapid-response 'crisis management process' for responding to things that 'worry us.'" News of the presentation was released by PressProgress (a left-wing news site launched by the Broadbent Institute, a social democratic think tank in Canada). Some local politicians in Toronto, where the conference took place, criticized the company and its executives' remarks, including Toronto City Councillor Gord Perks who tweeted "Hey [A&W Canada], I'm never buying from you again, and I will tell as many people as I can to avoid you too. Canadians have a constitutional right to bargain collectively. Leave Canada." A&W continues to grow its number of locations within the province of Ontario and Atkinson is now the dedicated Vice President, Ontario.
Sources: en.wikipedia.org
In that war, British submarines sank 2 million tons of enemy shipping and 57 major warships, the latter including 35 submarines. Among these is the only documented instance of a submarine sinking another submarine while both were submerged. This occurred when HMS Venturer engaged U-864; the Venturer crew manually computed a successful firing solution against a three-dimensionally maneuvering target using techniques which became the basis of modern torpedo computer targeting systems. Seventy-four British submarines were lost, the majority, forty-two, in the Mediterranean.
=== Definitive Edition === Following the first release of Black Mesa, the team announced work on a Definitive Edition, or Black Mesa 1.5, revamping non-Xen levels from the original Valve design to make them more challenging, as well as to take advantage of new lighting features available in the custom Source engine branch the game uses. This free update was released on November 25, 2020.
The number of actions needed to get the drug increases every time, so it becomes harder and harder to get the drug. The highest number of actions that the animal or human is willing to do to get the drug is called the break point. The higher the break point, the more the animal or human wants the drug. In contrast to the classical stimulants such as amphetamine, the effects of modafinil depend on what the animals or humans have to do after getting the drug. If they have to do a performance task, like solving a puzzle or remembering something, modafinil makes them work harder for it than placebo, and the subjects wanted to self-administer modafinil. But if they had to do a relaxation task, like listening to music or watching a video, the subjects did not want to self-administer modafinil. This suggests that modafinil is more rewarding when it helps the animals or humans do something better or faster, especially considering that modafinil is not commonly abused or depended on by people, unlike other stimulants.
=== Proteins === Proteins present in the hemolymph vary in quantity during the course of development. These proteins are classified by their functions: chroma proteins, protease inhibitors, storage, lipid transport, enzymes, the vitellogenins, and those involved in the immune responses of arthropods. Some hemolymphic proteins incorporate carbohydrates and lipids into the structure.
p A + q B ⇌ ApBq The study of these complexes is important for supramolecular chemistry and molecular recognition. The objective of these studies is often to find systems with a high binding selectivity of a host (receptor) for a particular target molecule or ion, the guest or ligand. An application is the development of chemical sensors. Finding a drug which either blocks a receptor, an antagonist which forms a strong complex the receptor, or activate it, an agonist, is an important pathway to drug discovery.
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.